“Lipella Pharmaceuticals Receives FDA Approval for Expanded Access Program of LP-310 in Oral Lichen Planus”
Pittsburgh Welcomes Lipella Pharmaceuticals Inc. February 6, 2025 – PRISM MediaWire Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) announced today Exciting news hit the biotechnology industry today as Lipella Pharmaceuticals Inc. announced its arrival in Pittsburgh. With a focus on developing innovative therapies for unmet medical needs, Lipella is set to make a significant impact in the…